Tandem Diabetes Care (TNDM) Insider Trading & Ownership $21.48 +1.50 (+7.51%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$21.32 -0.16 (-0.72%) As of 05/2/2025 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Tandem Diabetes Care (NASDAQ:TNDM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.90%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$203,312.24Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$858,400.00 Get TNDM Insider Trade Alerts Want to know when executives and insiders are buying or selling Tandem Diabetes Care stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TNDM Insider Buying and Selling by Quarter Tandem Diabetes Care Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/19/2025Josh GottheimerU.S. Congress Member (D-NJ)Sell$20.62$1,001 - $15,0003/7/2025Jean-Claude KyrillosCOOBuy10,538$18.12$190,948.56 3/4/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Buy$19.49$1,001 - $15,00011/20/2024Kim D BlickenstaffDirectorSell10,000$30.00$300,000.00 11/20/2024Kim D BlickenstaffDirectorSell10,000$30.00$300,000.00 11/15/2024Mark David NovaraEVPBuy532$23.24$12,363.68 8/5/2024Josh GottheimerU.S. Congress Member (D-NJ)Buy$40.79$1,001 - $15,0005/30/2024Dick AllenDirectorSell5,000$51.68$258,400.00 (Data available from 1/1/2013 forward) TNDM Insider Trading Activity - Frequently Asked Questions Who is on Tandem Diabetes Care's Insider Roster? The list of insiders at Tandem Diabetes Care includes Christopher J Twomey, David B Berger, Dick Allen, Jean-Claude Kyrillos, John F Sheridan, Kathleen Mcgroddy-Goetz, Kim D Blickenstaff, Leigh Vosseller, Mark David Novara, and Shannon Marie Hansen. Learn more on insiders at TNDM. What percentage of Tandem Diabetes Care stock is owned by insiders? 1.90% of Tandem Diabetes Care stock is owned by insiders. Learn more on TNDM's insider holdings. Which Tandem Diabetes Care insiders have been buying company stock? The following insiders have purchased TNDM shares in the last 24 months: Dick Allen ($389,500.00), Jean-Claude Kyrillos ($190,948.56), Kathleen Mcgroddy-Goetz ($21,450.00), Leigh Vosseller ($194,219.55), Mark David Novara ($12,363.68), and Shannon Marie Hansen ($29,876.40). How much insider buying is happening at Tandem Diabetes Care? Insiders have purchased a total of 38,220 TNDM shares in the last 24 months for a total of $838,358.19 bought. Which Tandem Diabetes Care insiders have been selling company stock? The following insiders have sold TNDM shares in the last 24 months: Dick Allen ($258,400.00), and Kim D Blickenstaff ($600,000.00). How much insider selling is happening at Tandem Diabetes Care? Insiders have sold a total of 25,000 Tandem Diabetes Care shares in the last 24 months for a total of $858,400.00 sold. Which members of congress are trading Tandem Diabetes Care? Gilbert Ray Cisneros, Jr. (D-CA) and Josh Gottheimer (D-NJ) have bought shares of Tandem Diabetes Care in the last year totaling $16,000. Josh Gottheimer (D-NJ) has sold shares totaling $8,000. Tandem Diabetes Care Key ExecutivesMr. John F. Sheridan (Age 69)President, CEO & Director Compensation: $988.35kMs. Leigh A. Vosseller (Age 50)Executive VP, CFO & Treasurer Compensation: $543.38kMs. Susan M. Morrison (Age 45)Executive VP & Chief Administrative Officer Compensation: $538.21kMr. David B. Berger Esq. (Age 54)Transitional Advisor Compensation: $543.38kMr. Brian B. Hansen (Age 56)Executive Officer Compensation: $561.74kMs. Elizabeth Anne Gasser (Age 48)Executive Vice President and Chief Strategy & Product Officer Compensation: $542.91kMr. Mark Novara (Age 49)Executive VP & Chief Commercial Officer Compensation: $169.6kMr. Rick A. Carpenter (Age 61)Chief Technical Officer Ms. Shannon M. Hansen (Age 58)Executive VP, Chief Legal, Privacy & Compliance Officer and Secretary Mr. Tom FoxChief Human Resources Officer More Insider Trading Tools from MarketBeat Related Companies SLNO Insider Trades IRTC Insider Trades TMDX Insider Trades PRCT Insider Trades NVST Insider Trades LMAT Insider Trades NVCR Insider Trades LIVN Insider Trades ENOV Insider Trades WRBY Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles McDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why This page (NASDAQ:TNDM) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhile fear dominates the headlines, a silent breakthrough could turn panic into profit. The future of AI fa...True Market Insiders | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tandem Diabetes Care With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.